Stanford University
Showing 10,501-10,520 of 36,204 Results
-
Bernd Girod
Robert L. and Audrey S. Hancock Professor in the School of Engineering, Emeritus
Current Research and Scholarly InterestsGirod's research focuses on algorithms and systems for multimedia analysis and communication. Applications range from wireless media delivery to interactive video streaming to mobile visual search and augmented reality.
-
Skyler Giron
Affiliate, Neurosurgery
BioCIRM Bridges Intern in the Llorente Lab, Stanford University Department of Neurosurgery
-
Anna Girsen
Director of Finance and Administration, Obstetrics & Gynecology
Current Role at StanfordAs Director of Finance and Administration for Stanford’s Department of Obstetrics & Gynecology, I lead strategic, financial, and operational functions supporting clinical care, research, and education. I oversee a $60M portfolio spanning hospital partnerships, research administration, and faculty affairs—advancing innovation, equity, and precision health across Stanford Medicine.
-
Dr Michael Gisondi
Professor of Emergency Medicine (Adult Clinical/Academic)
BioDr. Michael A. Gisondi is Professor of Emergency Medicine and Assistant Dean for Academic Advising at Stanford School of Medicine. He is a medical education researcher and the Principal of The Precision Education and Assessment Research Lab (The PEARL). Dr. Gisondi a Distinguished Member of the Stanford Medicine Teaching and Mentoring Academy and the recipient of numerous prestigious teaching awards, including the National Faculty Teaching Award of the American College of Emergency Physicians and the Hal Jayne Excellence in Education Award of the Society for Academic Emergency Medicine. Loyola University Chicago Stritch School of Medicine recognized him as Alumnus of the Year in 2014.
-
Aaron D. Gitler
Stanford Medicine Basic Science Professor
Current Research and Scholarly InterestsWe investigate the mechanisms of human neurodegenerative diseases, including Alzheimer disease, Parkinson disease, and ALS. We don't limit ourselves to one model system or experimental approach. We start with yeast, perform genetic and chemical screens, and then move to other model systems (e.g. mammalian tissue culture, mouse, fly) and even work with human patient samples (tissue sections, patient-derived cells, including iPS cells) and next generation sequencing approaches.
